Company Overview of Horizon Pharma plc
Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally. It offers ACTIMMUNE for reducing the frequency and severity of serious infections associated with chronic granulomatous disease; DUEXIS, a proprietary tablet formulation for the relief of signs and symptoms of rheumatoid arthritis (RA) and osteoarthritis (OA), and to decrease the risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for these indications; PENNSAID for the treatment of pain of OA ...
1 Burlington Road
Founded in 2005
Key Executives for Horizon Pharma plc
Chairman, Chief Executive Officer and President
Total Annual Compensation: $982.3K
Chief Financial Officer and Executive Vice President of Finance
Total Annual Compensation: $210.9K
Chief Business Officer and Executive Vice President
Total Annual Compensation: $492.0K
Chief Medical Officer and Executive Vice President of Research & Development
Total Annual Compensation: $396.3K
Chief Commercial Officer and Executive Vice President
Total Annual Compensation: $194.5K
Compensation as of Fiscal Year 2014.
Horizon Pharma plc Key Developments
Horizon Pharma plc(NasdaqGS:HZNP) dropped from Russell 2000 Index
Jun 29 15
Horizon Pharma plc will be removed from Russell 2000 Index
Horizon Pharma plc(NasdaqGS:HZNP) dropped from Russell 3000 Index
Jun 29 15
Horizon Pharma plc will be removed from Russell 3000 Index.
Horizon Pharma plc Presents at BIO International Convention 2015, Jun-18-2015 09:45 AM
Jun 11 15
Horizon Pharma plc Presents at BIO International Convention 2015, Jun-18-2015 09:45 AM. Venue: Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries